Skip to main content

Advertisement

SpringerLink
Log in

Endothelial nitric oxide synthase polymorphisms and hypertension

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

The human endothelial nitric oxide synthase (eNOS) gene is highly polymorphic. Evidence for the involvement of eNOS single nucleotide polymorphisms in the development of essential hypertension is limited, though the eNOS Glu298Asp polymorphism appears to influence the blood pressure response to exercise. This variant also influences endothelial function, with its effects becoming manifest during the adaptive vascular changes of pregnancy. Carriers of eNOS Asp298 may be at risk of developing pre-eclampsia. Molecular studies have indicated that intact eNOS Asp298 has equivalent enzymatic activity to eNOS Glu298, but undergoes selective proteolysis in native cells and tissues such that the steady state level of active eNOS may be reduced in carriers of this allele. Carriers of eNOS Asp298, particularly if exposed to adverse environmental infuences on endothelial function, may be at increased risk of developing atherosclerosis and cerebrovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Mongeau J-G: Heredity and blood pressure. Semin Nephrol 1989, 9:208–216.

    PubMed  CAS  Google Scholar 

  2. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell 2001, 104:545–556. This study shows that in a few rare instances a hypertensive phenotype clinically indistinguishable from indiopathic (essential) hypertension can result from mutations in single genes that alter renal sodium handling.

    Article  PubMed  CAS  Google Scholar 

  3. Hingorani AD, Vallance P: Endothelial nitric oxide. In Vascular Endothelium in Human Physiology and Pathophysiology. Edited by Vallance PJT, Webb DJ. London: Harwood Academic; 2000.

    Google Scholar 

  4. Vallance P: Exploring vascular nitric oxide in health and disease. The Goulstonian Lecture. J R Coll Physicians Lond 1996, 31:321–327.

    Google Scholar 

  5. Bath PM: The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro. Eur J Clin Pharmacol 1993, 45:53–58.

    Article  PubMed  CAS  Google Scholar 

  6. Radomski MW, Palmer RM, Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A 1990, 87:5193–5197.

    Article  PubMed  CAS  Google Scholar 

  7. Cooke JP, Dzau VJ: Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997, 48:489–509.

    Article  PubMed  CAS  Google Scholar 

  8. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524–526.

    Article  PubMed  CAS  Google Scholar 

  9. Vallance P, Collier J, Moncada S: Effects of endotheliumderived nitric oxide on peripheral arteriolar tone in man [see comments]. Lancet 1989, 2:997–1000.

    Article  PubMed  CAS  Google Scholar 

  10. Haynes WG, Noon JP, Walker BR, Webb DJ: Inhibition of nitric oxide synthesis increases blood pressure in healthy humans [see comments]. J Hypertens 1993, 11:1375–1380.

    Article  PubMed  CAS  Google Scholar 

  11. Haynes WG, Hand MF, Dockrell ME, et al.: Physiological role of nitric oxide in regulation of renal function in humans. Am J Physiol 1997, 272:F364-F371.

    PubMed  CAS  Google Scholar 

  12. Lahera V, Salom MG, Fiksen-Olsen MJ, Romero JC: Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin. Am J Hypertens 1991, 3:260–262.

    Google Scholar 

  13. Salom MG, Lahera V, Miranda-Guardiola F, Romero JC: Blockade of pressure natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs. Am J Physiol 1992, 262:F718-F722.

    PubMed  CAS  Google Scholar 

  14. Ito S, Ren Y: Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest 1993, 92:1093–1098.

    PubMed  CAS  Google Scholar 

  15. Henrich WL, McAllister EA, Smith PB, Campbell WB: Guanosine 3’,5’-cyclic monophosphate as a mediator of inhibition of renin release. Am J Physiol 1988, 255:F474-F479.

    PubMed  CAS  Google Scholar 

  16. Moncada S, Palmer RM, Higgs EA: The biological significance of nitric oxide formation from L-arginine. Biochem Soc Trans 1989, 17:642–644.

    PubMed  CAS  Google Scholar 

  17. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension [see comments]. N Engl J Med 1990, 323:22–27.

    Article  PubMed  CAS  Google Scholar 

  18. Calver A, Collier J, Moncada S, Vallance P: Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992, 10:1025–1031.

    Article  PubMed  CAS  Google Scholar 

  19. Forte P, Copland M, Smith LM, et al.: Basal nitric oxide synthesis in essential hypertension [see comments]. Lancet 1997, 349:837–842.

    Article  PubMed  CAS  Google Scholar 

  20. Cardillo C, Kilcoyne CM, Quyyumi AA, et al.: Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 1998, 97:851–856.

    PubMed  CAS  Google Scholar 

  21. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM: Preserved endothelium-dependent vasodilatation in patients with essential hypertension [see comments]. N Engl J Med 1995, 330:1036–1040.

    Article  Google Scholar 

  22. Chowienczyk PJ, Cockcroft JR, Ritter JM: Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature. Br J Pharmacol 1993, 110:736–738.

    PubMed  CAS  Google Scholar 

  23. Gerhard M, Roddy MA, Creager SJ, Creager MA: Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996, 27:849–853.

    PubMed  CAS  Google Scholar 

  24. Calver A, Collier J, Vallance P: Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension [see comments]. Cardiovasc Res 1994, 28:1720–1725.

    PubMed  CAS  Google Scholar 

  25. Lyons D, Webster J, Benjamin N: The effect of antihypertensive therapy on responsiveness to local intra-arterial NG-monomethyl-L-arginine in patients with essential hypertension. J Hypertens 1994, 12:1047–1052.

    PubMed  CAS  Google Scholar 

  26. Creager MA, Roddy MA: Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 1994, 24:499–505.

    PubMed  CAS  Google Scholar 

  27. Panza JA, Quyyumi AA, Callahan TS, Epstein SE: Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993, 21:1145–1151.

    Article  PubMed  CAS  Google Scholar 

  28. Taddei S, Virdis A, Mattei P, et al.: Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996, 94:1298–1303.

    PubMed  CAS  Google Scholar 

  29. Cosentino F, Patton S, d’Uscio LV, et al.: Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998, 101:1530–1537.

    Article  PubMed  CAS  Google Scholar 

  30. Heitzer T, Brockhoff C, Mayer B, et al.: Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res 2000, 86:E36-E41.

    PubMed  CAS  Google Scholar 

  31. Boger RH, Bode SM, Szuba A, et al.: Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998, 98:1842–1847.

    PubMed  CAS  Google Scholar 

  32. Vallance P, Leone A, Calver A, et al.: Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992, 20(Suppl 12):S60-S62.

    PubMed  CAS  Google Scholar 

  33. Grunfeld S, Hamilton CA, Mesaros S, et al.: Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995, 26:854–857.

    PubMed  CAS  Google Scholar 

  34. Huang PL, Huang Z, Mashimo H, et al.: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377:239–242.

    Article  PubMed  CAS  Google Scholar 

  35. Kuhlencordt PJ, Gyurko R, Han F, et al.: Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001, 104:448–454. This study shows that eNOS deletion enhances atherosclerosis in apoE-deficient mice independent of blood pressure changes.

    PubMed  CAS  Google Scholar 

  36. Marsden PA, Heng HH, Scherer SW, et al.: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993, 268:17478–17488.

    PubMed  CAS  Google Scholar 

  37. Hingorani AD, Liang CF, Fatibene J, et al.: A common variant of the endothelial nitric oxide synthase Glu298Asp is a major risk factor for coronary artery disease in the UK. Circulation 1999, 100:1515–1520.

    PubMed  CAS  Google Scholar 

  38. Miyamoto Y, Saito Y, Kajiyama N, et al.: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998, 32:3–8.

    PubMed  CAS  Google Scholar 

  39. Jeerooburkhan N, Jones LC, Bujac S, et al.: Genetic and environmental determinants of nitric oxide in man. Hypertension 2001, 38:1054–1061. This results of this study raise the possibility that the intron 4 variant might act as a marker in linkage disequilibrium with potential functional variants in the regulatory region of the gene.

    PubMed  CAS  Google Scholar 

  40. Nakayama N, Yasue H, Yoshimura M, et al.: T-786 — C Mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene is associated with coronry spasm. Circulation 1999, 99:2864–2870.

    PubMed  CAS  Google Scholar 

  41. Shimasaki Y, Yasue H, Yoshimura M, et al.: Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998, 31:1506–1510.

    Article  PubMed  CAS  Google Scholar 

  42. Bonnardeaux A, Nadaud S, Charru A, et al.: Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 1995, 91:96–102.

    PubMed  CAS  Google Scholar 

  43. Hunt SC, Williams CS, Sharma AM, et al.: Lack of linkage between the endothelial nitric oxide synthase gene and hypertension. J Hum Hypertens 1996, 10:27–30.

    PubMed  CAS  Google Scholar 

  44. Kato N, Sugiyama T, Morita H, et al.: Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 1999, 33:933–936.

    PubMed  CAS  Google Scholar 

  45. Shoji M, Tsutaya S, Saito R, et al.: Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci 2000, 66:2557–2562.

    Article  PubMed  CAS  Google Scholar 

  46. Kajiyama N, Saito Y, Miyamoto Y, et al.: Lack of association between T-786→C mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene and essential hypertension. Hypertens Res 2000, 23:561–565.

    PubMed  CAS  Google Scholar 

  47. Jachymova M, Horky K, Bultas J, et al.: Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun 2002, 284:426–430.

    Article  CAS  Google Scholar 

  48. Karvonen J, Kauma H, Kervinen K, et al.: Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 2002, 251:102–110.

    Article  PubMed  CAS  Google Scholar 

  49. Chen W, Srinivasan SR, Elkasabany A, et al.: Combined effects of endothelial nitric oxide synthase gene polymorphism (G894T) and insulin resistance status on blood pressure and familial risk of hypertension in young adults: the Bogalusa Heart Study. Am J Hypertens 2001, 14:1046–1052.

    Article  PubMed  CAS  Google Scholar 

  50. Tsujita Y, Baba S, Yamauchi R, et al.: Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: The Suita Study. J Hypertens 2001, 19:1941–1948.

    Article  PubMed  CAS  Google Scholar 

  51. Lacolley P, Gautier S, Poirier O, et al.: Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 1998, 16:31–35.

    Article  PubMed  CAS  Google Scholar 

  52. Robson SC, Hunter S, Boys RJ, Dunlop W: Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989, 256:H1060-H1065.

    PubMed  CAS  Google Scholar 

  53. Williams DJ, Vallance PJ, Neild GH, et al.: Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 1997, 272:H748-H752.

    PubMed  CAS  Google Scholar 

  54. Seligman SP, Buyon JP, Clancy RM, et al.: The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994, 171:944–948.

    PubMed  CAS  Google Scholar 

  55. Arngrimsson R, Hayward C, Nadaud S, et al.: Evidence for a familial pregnancy-induced hypertension locus in the eNOSgene region. Am J Hum Genet 1998, 61:354–362.

    Google Scholar 

  56. Guo G, Lade JA, Wilton AN, et al.: Genetic susceptibility to preeclampsia and chromosome 7q36. Hum Genet 1999, 105:641–647.

    Article  PubMed  CAS  Google Scholar 

  57. Yoshimura T, Yoshimura M, Tabata A, et al.: Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Invest 2000, 7:238–241.

    Article  CAS  Google Scholar 

  58. Savvidou M, Vallance PJ, Nicolaides K, Hingorani AD: Glu298Asp polymorphism of endothelial nitric oxide synthase and the vascular response to normal pregnancy. Hypertension 2001, 38:1289–1293.

    PubMed  CAS  Google Scholar 

  59. Ichihara S, Yamada Y, Fujimura T, et al.: Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998, 81:83–86.

    Article  PubMed  CAS  Google Scholar 

  60. Hibi K, Ishigami T, Tamura K, et al.: Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998, 32:521–526.

    PubMed  CAS  Google Scholar 

  61. Markus HS, Ruigrok Y, Ali N, Powell JF: Endothelial nitric oxide synthase exon 7 polymorphism, ischaemic cerebrovascular disease, and carotid atheroma. Stroke 1998, 29:1908–1911.

    PubMed  CAS  Google Scholar 

  62. Zanchi A, Moczulski DK, Hanna LS, et al.: Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 2000, 57:405–413.

    Article  PubMed  CAS  Google Scholar 

  63. Persu A, Stoenoiu MS, Messiaen T, et al.: Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Molecular Genet 2002, 11:229–241.

    Article  CAS  Google Scholar 

  64. Hingorani AD: Polymorphisms in endothelial nitric oxide synthase and atherogenesis. The John French Lecture 2000. Atherosclerosis 2001, 154:521–527.

    Article  PubMed  CAS  Google Scholar 

  65. Tesauro M, Thompson WC, Rogliani P, et al.: Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 2000, 97:2832–2835.

    Article  PubMed  CAS  Google Scholar 

  66. Rankinen T, Rice T, Perusse L, et al.: NOS3 Glu298Asp genotype and blood pressure response to endurance training. The HERITAGE family study. Hypertension 2000, 36:885–889.

    PubMed  CAS  Google Scholar 

  67. Naber CK, Baumgart D, Altmann C, et al.: eNOS 894T allele and coronary blood flow at rest and during adenosineinduced hyperemia. Am J Physiol 2001, 281:H1908-H1912.

    CAS  Google Scholar 

  68. Philip I, Plantefeve G, Villaumier Barrot G, et al.: G894T polymorphism in eNOS is associated with enhanced vascular response to phenylephrine. Circulation 1999, 99:3096–3098.

    PubMed  CAS  Google Scholar 

  69. Savvidou M, Nicolaides K, Vallance P, Hingorani AD: Glu29Asp polymorphism of the endothelial nitric oxide synthase and the vascular response to normal pregnancy. Hypertension 2001, 38:1289–1293.

    PubMed  CAS  Google Scholar 

  70. Leeson CP, Hingorani AD, Mullen MJ, et al.: Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res 2002, 90:1153–1158.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. BHF Laboratories at UCL, Centre for Clinical Pharmacology, Rayne Building, 5 University Street, WC1E 6JF, London, UK

    Aroon D. Hingorani MD

Authors
  1. Aroon D. Hingorani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hingorani, A.D. Endothelial nitric oxide synthase polymorphisms and hypertension. Current Science Inc 5, 19–25 (2003). https://doi.org/10.1007/s11906-003-0006-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-003-0006-0

Keywords

Search

Navigation